ANEB

Anebulo Pharmaceuticals

Delisted

ANEB was delisted on the 27th of February, 2026.

10 hedge funds and large institutions have $25.8M invested in Anebulo Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

6% less capital invested

Capital invested by funds: $27.5M → $25.8M (-$1.65M)

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$127K
2 +$3.32K
3 +$1.33K
4
Morgan Stanley
Morgan Stanley
New York
+$13

Top Sellers

1 -$62.9K
2 -$1.78K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$20.7M
2
$2.5M
3
$1.4M
4
$1.07M
5
$110K
6
$49K
7
$4K
8
$3K
9